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Identification of a Wnt/Dvl/-Catenin → Pitx2
Pathway Mediating Cell-Type-Specific
Proliferation during Development
Introduction
Coordinated transcriptional regulation of cell prolifera-
tion, in addition to differentiation, is a central feature in
development of all organs. Many tissue-restricted tran-
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kinase glycogen synthase kinase 3 (GSK-3). In theGermany
absence of Wnt signaling, -catenin (armadillo in Dro-
sophila) is found in a multi-protein complex containing
adenomatous polyposis coli (APC), and axin, targeting
-catenin for ubiquitin-dependent degradation. Activa-Summary
tion of Dvl inhibits GSK-3 within this complex leading
to the stabilization and accumulation of -catenin inUnderstanding the cell type-specific molecular mech-
the cytoplasm. Upon nuclear translocation, -cateninanisms by which distinct signaling pathways combina-
interacts with members of the TCF/LEF family of DNAtorially control proliferation during organogenesis is
binding molecules to influence target gene expressiona central issue in development and disease. Here, we
(Boutros and Mlodzik, 1999). In addition to its role inreport that the bicoid-related transcription factor Pitx2
mediating the classical Wnt pathway, Drosophila Dshis rapidly induced by the Wnt/Dvl/-catenin pathway
participates in planar cell polarity (Heslip et al., 1997)and is required for effective cell-type-specific prolifer-
and Notch signaling pathways (Axelrod et al., 1996).ation by directly activating specific growth-regulating
Three highly related Dvl genes and proteins have beengenes. Regulated exchange of HDAC1/-catenin con-
isolated in mice and humans, and their expression pat-verts Pitx2 from repressor to activator, analogous to
terns overlapped significantly during mouse develop-control of TCF/LEF1. Pitx2 then serves as a compe-
ment (reviewed in Hamblet et al., 2002).tence factor required for the temporally ordered and
-catenin is proposed to bind to the TCF/LEF familygrowth factor-dependent recruitment of a series of
of transcription factors, changing them from repressorsspecific coactivator complexes that prove necessary
to activators of transcription primarily by displacing the
for Cyclin D2 gene induction. The molecular strategy
groucho/TLE corepressor (Fisher and Caudy, 1998).
underlying interactions between the Wnt and growth
However, given the expression patterns of the known
factor-dependent signaling pathways in cardiac out- TCF/LEFs, -catenin may additionally bind to other tis-
flow tract and pituitary proliferation is likely to be pro- sue-restricted transcription factors to modulate specific
totypic of cell-specific proliferation strategies in other aspects of Wnt signaling. A subset of organs where
tissues. the Wnt signals provide critical regulation express a
subfamily of bicoid-related factors, consisting of three
Pitx factors that exert distinct roles in development. One
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et al., 1996). Pitx2-deficient mice are characterized by PTA (88% penetrance) (Figure 1E). In situ hybridization
revealed a marked decrease of Pitx2 expression in thefailure of body-wall closure, arrest in turning, ocular de-
fects, right pulmonary isomerism, altered cardiac posi- migrating cells of the fourth-sixth branchial arches in
e11 mice, while Pax3 positive cells were still presenttion with valvular and atrial septation defects, and a
block in early determination events in anterior pituitary (Figure 1F). Thus, our genetic data suggest that Pitx2 is
a component of the Wnt/Dvl/-catenin pathway.gland and tooth organogenesis (Gage et al., 1999; Kita-
mura et al., 1999; Lin et al., 1999; Lu et al., 1999). Coexpression of Pitx2 and Wnt-1-Cre-activated -gal
(from ROSA26-lacZ reporter mice) was found in the mi-In this manuscript, we report that induction of tissue-
restricted competence factors, exemplified by Pitx2, gratory cell population of the fourth and sixth branchial
arches of e10 embryos (Figure 1G), suggesting that Pitx2acting in combination with general growth factor signal-
ing pathways to mediate cell type-specific control of is expressed in cardiac neural crest. Neural crest out-
growth cultures from e8.5 midotic to 3rd somite areaproliferation. The Wnt/Dvl/-catenin→Pitx2 pathway
operates in specific tissues to control proliferation by were assessed for colocalization of Pitx2 and connexin
43 (Cx43), suggested to be a reliable marker of cardiacregulating expression of critical cell cycle control genes
in G1. The Wnt pathway directly induces Pitx2 and addi- neural crest (Waldo et al., 1999). Twenty-nine percent
of the cells examined in the stack of deconvolution mi-tional growth factor-dependent signaling results in dis-
missal of Pitx2-associated corepressors and mediates croscopic images were Cx43 and approximately one
third of them coexpressed nuclear Pitx2 (Figure 1H).recruitment of specific coactivator complexes to growth
regulatory target genes such as Cyclin D2. Pitx2, positive (blue) cells fail to migrate to the cardiac
truncus at e9.5 Pitx2/ mice (Figure 1I). Therefore, we
suggest that mutation of the Pitx2 gene causes a defectResults
in cardiac outflow tract based on events in cardiac neu-
ral crest, consistent with the phenotype of the Wnt-1A Wnt/Dvl2/-Catenin → Pitx2 Pathway
Cre/-catenin gene deletion.Is Essential for Cardiac Outflow
Tract Development
In addition to the previously described nonseptated The Wnt/-Catenin Pathway Induces Pitx2
Gene Expressionatrium and valvular deficiencies (Gage et al., 1999; Kita-
mura et al., 1999; Lin et al., 1999; Lu et al., 1999), we We took advantage of the ability of lithium to suppress
GSK-3activity, an effect that mimics Wnt pathway activa-noted that the Pitx2/ mice that survive up to e14, invari-
antly exhibit major cardiac outflow tract abnormalities, tion (Hedgepeth et al., 1997), to examine whether Pitx2
expression could be induced by-catenin. After injectionwhich are best classified as persistent truncus arterio-
sus abnormalities (PTA), (70%) and incomplete septa- of lithium chloride (LiCl) (4 ng/g body weight) intraperito-
neally to Pitx2/ mothers, e9.75 Pitx2/ heterozygoustion of the great arteries (30%) that may develop with
double outlet right ventricle (DORV) or transposition of embryos (harvested 2 hr later) revealed a consistent,
marked increase in Pitx2-driven LacZ expression of thethe great arteries (TGA) (Figure 1A). Deletion of the Dvl2
gene (Hamblet et al., 2002) resulted in a cardiac outflow bulbo-truncal junction region of the outflow tract of the
heart (Figure 2A), as well as in other Pitx2-expressingtract phenotype similar to that of the Pitx2/ mouse
(Figure 1B). Thus, PTA, DORV, and TGA are observed organs, including pituitary, eye, and muscle (Figures 2A,
2B, and data not shown). These data further suggestin 60% of Dvl2/ mice, shown in Figure 1B, serving
as the cause of death. In the Dvl2/ mice, there was a that the Wnt/-catenin pathway regulate Pitx2 gene ex-
pression in several tissues.marked decrease in Pitx2 expression in a population
of cells, potentially cardiac neural crest, located in the Because development of the anterior pituitary gland
is arrested in Pitx2/ mice (Gage et al., 1999; Kitamurafourth and sixth branchial arches and migrating to the
cardiac outflow tract (Figure 1C), while Pax3 positive et al., 1999; Lin et al., 1999; Lu et al., 1999), we investi-
gated the effects of lithium in dissociated pituitary cellscells were still present, suggesting that Pitx2 is a down-
stream target of Dvl2-mediated pathways in cardiac out- and organ culture. Addition of LiCl caused a rapid,
marked increase in Pitx2 expression in isolated e11.5flow tract development.
If a Dvl-dependent pathway directly regulates Pitx2 pituitaries cultured on collagen gel (data not shown) or
primary cell cultures prepared from e10.5 pituitaries ofin cardiac neural crest cell development, then genetic
interaction between Dvl2 and Pitx2 might be expected. Pitx2/ mice. In the absence of LiCl, proliferating cells
expressed low levels of the pituitary-specific marker,More than 65% of Dvl2//Pitx2/ mice exhibited unam-
biguous outflow tract abnormalities, particularly PTA Lhx3 (data not shown), but displayed no significant Pitx2
expression (as marked by LacZ) (Figure 2C). Addition of(Figure 1D). Because Dvl can serve as component of
pathways other than Wnt, we determined whether lithium to these cultures resulted in marked induction
of Pitx2, clearly detected as -gal expression in virtually-catenin is also required for outflow tract development.
The expression of a Wnt1/Cre transgene, expressed in every cell by 1–2 hr (Figure 2C, and data not shown).
To further test a potential direct Wnt/Dvl → Pitx2 path-CNS/craniofacial regions and in cardiac neural crest (Ji-
ang et al., 2000), permitted conditional deletion of floxed way, we expressed a constitutively active form of
-catenin (-cateninc) that exhibits nuclear localization-catenin alleles (Brault et al., 2001). Our examination
of e10.5–e17.5 embryos with Wnt1/Cre-dependent dele- in the absence of Wnt signals (Aberle et al., 1997) with
a selectable marker into the T3-1 pituitary cell line. Cellstion of floxed -catenin alleles in the neural crest re-
vealed the occurrence of cardiac outflow tract abnor- expressing -cateninc exhibited a marked induction of
the Pitx2 gene expression (Figure 2D). Similar resultsmalities in almost all embryos evaluated, particularly
Wnt/Pitx2 Pathway in Cell-Specific Proliferation
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Figure 1. Genetic Evidence of Pitx2, Dvl2, and -Catenin Roles in Cardiac Outflow Tract Development
(A) Scanning Electron Microscopy (SEM) (1,2) and hematoxylin and eosin H&E stained serial sections (3-5) from e14.5 hearts show PTA. Two
different examples of PTA are shown (4,5), with three of the four cushions present seen in the single section shown (asterisk).
(B) SEM (1) and H&E staining (2) of heart revealed deficient positioning of the great arteries (DORV type) in e18.5 Dvl2/ mice.
(C) Dvl2/ mice failed to express Pitx2 RNA, but do express Pax3 transcripts in the fourth and sixth branchial arches (BA).
(D) Pitx2// Dvl2/ mutant mice exhibit cardiac outflow tract abnormalities. SEM (1-2) and H&E sections (3,5) of e18.5 (3) and e14.5 (4,5)
hearts of these double heterozygotes.
(E) Serial sections of an e17.5 Wnt-1 Cre/-cateninflox gene-deleted heart characterized by common truncus.
(F) The Wnt-1 Cre /-cateninflox e10.5 mice exhibit marked decrease or absence of Pitx2 expression in the fourth branchial arch.
(G) Pitx2 is expressed in Wnt-1 positive cells. Double labeling immunohistochemistry for Pitx2 and -galactosidase, which detects Wnt-1
expression in e10.5 Wnt-1 Cre mice.
(H) Pitx2 is expressed in Connexin-43 positive cells. Double labeling immunohistochemistry and confocal microscopy was performed in primary
branchial arch cultures from e8.5 mice for Pitx2 and Cx43 following migration of neural crest cells, with studies confirming colocalization of both
proteins in the migrating cardiac neural crest cells.
(I) Pitx2-expressing cells are diminished in the e9.5 cardiac outflow tract of Pitx2/ mice when compared with the Pitx2/ littermates by LacZ
whole-mount staining.
Ao  Aorta; PA  Pulmonary Artery; RA  Right Atrium; LA  Left Atrium; LV  Left Ventricle; RV Right Ventricle; TA  Truncus Arteriosus;
OT  outflow tract, C  cytoplasm, N  nucleus.
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Figure 2. A Wnt/Dvl → Pitx2 Pathway
(A) In vivo treatment with lithium induces Pitx2 expression in tissues including the developing cardiac outflow tract.
(B) Stimulation of Pitx2/-gal expression in the anterior pituitary (arrow).
(C) Lithium-induced Pitx2 expression in pituitary primary cell cultures.
(D) Constitutively active -catenin (-cateninc) induces Pitx2 gene expression in populations of stably transfected T3-1 pituitary cells.
(E) LEF1 acts as an HDAC1-dependent repressor, reversed by addition of lithium.
(F) -catenin reverses LEF1/HDAC1 repression of Pitx2 by dismissal of HDAC1. The sequence of the murine Pitx2 promoter was determined,
with conservation of two TCF/LEF responsive elements (RE). The effect of lithium on activation of -catenin-dependent events was assessed
in T3-1 cells using ChIP analysis. LEF1was detected on the Pitx2 promoter, as was HDAC1, but not HDAC2 or N-CoR.
were obtained in a second Pitx2-expressing cell line detected, but -catenin was now present on the Pitx2
promoter (Figure 2F). These data suggest that Pitx2 is(C2C12, data not shown). In the absence of lithium chlo-
ride, LEF1 can function as an inhibitor, relieved by either a direct target of the Wnt/Dvl pathway, and single cell
nuclear microinjection LEF1 specifically blocks stimu-lithium chloride or nuclear microinjection of HDAC1
IgG (Figure 2E) (Billin et al., 2000). lation of a Pitx2/LacZ reporter by LiCl (data not shown).
Interestingly, the 5 regulatory regions of the human
Pitx2 gene contain perfect consensus TCF/LEF re- Pitx2/ Mice Exhibit a Proliferation Defect
in Cardiac Neural Crest and Rathke’s Pouchsponse elements. Addition of LiCl or -cateninc expres-
sion caused an induction of the Pitx2 promoter in tran- To determine whether the actions of Pitx2 in cardiac
neural crest reflected, at least in part, a proliferativesient transfection assays (data not shown). We cloned
and determined the sequence of the murine Pitx2 pro- defect, we performed BrdU pulse-labeling experiments
on e9–e11 embryos and analyzed -gal /BrdU colocali-moter and established that two TCF/LEF response ele-
ments were conserved in the mouse promoter, one iden- zation. As shown in Figure 3A, there was a marked de-
crease in BrdU labeling of cells that normally expresstical with the human promoter sequence (Figure 2F).
Chromatin immunoprecipitation (ChIP) assays were per- Pitx2 migrating from the fourth and sixth branchial
arches to the developing cardiac outflow tract in Pitx2/formed as previously described (Jepsen et al., 2000;
Baek et al., 2002; Scully et al., 2000) using specific IgGs mice, as compared to their Pitx2/ littermates. Similarly,
BrdU pulse labeling of embryos carrying a Wnt-1-Cre-against -catenin, LEF1, N-CoR and specific HDACs
revealing that LEF1 was present on the Pitx2 promoter dependent deletion of the -catenin alleles at e10.5 re-
vealed a marked decrease of labeled cells in outflow(Figure 2F). In untreated cells, HDAC1 was detected on
the Pitx2 promoter, but HDAC2, -catenin, and N-CoR tract (Figure 3B).
The absence of Pitx2 causes developmental arrest ofwere not. After lithium stimulation, HDAC1 was no longer
Wnt/Pitx2 Pathway in Cell-Specific Proliferation
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Figure 3. Pitx2 Regulates Cell Proliferation during Cardiac and Pituitary Development
(A) Dramatic decrease of BrdU incorporation in Pitx2/ cardiac outflow tract. Double labeling for BrdU (red) and -galactosidase (green),
showed a decrease of the Pitx2-positive proliferating cells in the cardiac outflow tract in mutant e9 mice compared to their heterozygote
littermates. Boxed region indicates magnification of the same sagittal section.
(B) Absence of proliferating cardiac neural crest cells in the Wnt-1-Cre/ -cateninflox mice in the fourth and sixth branchial arches of e11 Wnt-
1-Cre/-cateninflox mice.
(C) Decreased BrdU incorporation in Pitx2/ pituitaries, compared to wild-type littermate controls, following intraperitoneal injection at e9.
Quantitation revealed 60%–75% reduction of BrdU positive cells. Reduction of the pituitary gland at e14.5 in the Pitx2/ mice compared with
the Pitx2/ littermates.
(D) Effects of sustained expression of Pitx2 under 15 kb of Pit-1 gene regulatory information, founder analyses was performed at e17.5,
revealing particular expansion of the growth hormone (GH) positive cells.
(E) Decreased BrdU incorporation in pituitaries from Pitx1//Pitx2/ mice, compared to wild-type littermates following intraperitoneal injection
at e16.5.
(F) In situ analysis of e18.5 Pitx1//Pitx2/ mice exhibit a decrease in all pituitary cell types with particularly striking effects on growth
hormone and thyrotrope producing cells. The anterior pituitary gland was markedly hypoplastic, as shown by H&E staining of adjacent sections
(upper images).
AP  anterior pituitary; GH  growth hormone; TSH  thyrotrope stimulating hormone.
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the pituitary gland by e10.5 (Gage et al., 1999; Lin et al., we determined the requirement for DNA binding and other
domains of Pitx2 for its effects on cell proliferation. These1999), consistent with the shift in growth dependence
of Rathke’s pouch from extrinsic (FGFs, BMP4, Shh) to experiments utilized the Pitx2HDmut, a Pitx2a holoprotein in
which three amino acids involved in major groove contactsintrinsic signals (BMP2, Wnt) (Ericson et al., 1998; Treier
et al., 1998). The arrest of organ development proved in3 DNA binding helix of the homeodomain were mutated
(to alanine) to prevent sequence-specific DNA bindingto be due to a failure of proliferation, with 65 to 70%
reduction of the number of BrdU-labeled cells consis- without altering homeodomain structure. We also evalu-
ated Pitx2 N, which deleted all sequences N-terminal totently observed in the pituitary gland from Pitx2/ lin-
eages compared to the wild-type littermate controls the homeodomain of Pitx2a, and Pitx2 C, which deleted
all sequences C-terminal to the homeodomain of Pitx2a.(Figure 3C). A similar reduction in the number of BrdU-
labeled cells was seen in the body wall and limbs and Neither Pitx2HDmut, nor Pitx2 N, were able to rescue
the block of BrdU incorporation by Pitx2 IgG, whileno changes in apoptotic cells were detected in the devel-
oping pituitary of Pitx2/ mice (data not shown). Con- identical molar concentrations of nuclear microinjected
Pitx2 holoprotein or Pitx2 C rescued the growth inhib-versely, in vivo overexpression of Pitx2, under the con-
trol of 15 kb Pit-1 promoter (Treier et al., 1998), revealed iting effects of Pitx2 (Figures 4F and 4G). Conversely,
in the absence of Pitx2 IgG, the N-terminal domain ofhyperplasia of the anterior pituitary with one of the Pit-
1-dependent cell lineages, the somatotrope (GH pro- Pitx2 (Pitx2 N) or homeodomain (Pitx2HD), but not the
C terminus (Pitx2 C) or Pitx2a holoprotein, acted in aducing cell), particularly increased in number (2-fold),
with increased levels of growth hormone transcripts dominant-negative fashion, inhibiting BrdU incorpora-
tion in C2C12 cells (Figure 4F and data not shown).(Figure 3D).
Pitx2//Pitx1/ mice displayed a marked decrease These data establish that the DNA binding function of
Pitx2, and its N-terminal domain, are required for itsin BrdU incorporation on e16.5, resulting in hypoplastic
anterior pituitary (Figure 3E). The growth defect involves effects on proliferation.
Nuclear microinjection of Pitx2 holoprotein did notall pituitary cell types, except perhaps the POMC lineage,
with somatotrope proliferation being strikingly affected further stimulate BrdU incorporation in Rat1 cells in
which neither Pitx2 or Pitx1 are expressed (Figure 4H).(Figure 3F and data not shown), and is similar to that
previously described in Wnt4/ mice (Treier et al., 1998). Conversely,Pitx2 had no effect on proliferation in these
cells (Figure 4H). These data demonstrate that inhibition
of cell proliferation by Pitx2 is a specific effect ob-Pitx2 Regulates Cell-Autonomous Proliferation
served only in cell types that normally express Pitx2. InActing in G1
order to estimate the time in the cell cycle, at which Pitx2Based on genetic evidence linking Pitx2 to proliferation
might act in regulating cell proliferation, synchronizedin several organ systems, we next investigated whether
C2C12 cells were serum-treated and the effect of nu-Pitx2 might serve a cell-autonomous role directly regu-
clear microinjection of Pitx2, or preimmune, was as-lating proliferation of cells in which it is expressed. Be-
sessed at various times following serum addition. Pitx2cause Pitx2 is highly expressed in a subpopulation of
effectively inhibited BrdU incorporation for 6–8 hr; how-Pax3 migratory muscle precursor cells at e10.5 (Figure
ever, by 9 hr after serum stimulation, Pitx2 was no4A), and in pituitary, we could address this issue in both
longer effective at inhibiting BrdU (Figure 4I). Therefore,the well-characterized C2C12 murine myoblast cell line,
Pitx2 serves as a transcriptional regulator in early to latewhich can be induced to differentiate by withdrawal of
G1 in cells in which it is expressed.mitogens (Blau et al., 1985), and in the pituitary cell
line T3-1. Pitx2 transcripts (data not shown) and Pitx2
protein (Figure 4B) were expressed in undifferentiated Cyclin D2 Is a Pitx2 Target Gene
The next issue was whether Pitx2 might be involved inC2C12 cells, with decreasing levels after 3 days of differ-
entiation. There was a reproducible 70%–80% decrease induction of specific growth control genes, particularly
those regulated in early/mid G1. Examination of thein BrdU incorporation in serum-treated cells microin-
jected with specific Pitx2, but not with preimmune IgG Cyclin D2 promoter revealed that it contained consen-
sus bicoid binding sites (Figure 5A), as did the Cyclin(Figure 4C). A similar result was obtained in T3-1 cells
and SiRNA against Pitx2 transcripts and gave similar D1 and c-Myc promoters. Double-stranded oligonucleo-
tides corresponding to the two most conserved Pitx2results in both cell types (data not shown). These effects
were observed when EGF, IGF-1, and FGF were used cognate binding sites could be bound by bacterially
expressed Pitx2a by EMSA (data not shown) and there-to stimulate growth (data not shown). Serum or growth
factor activation of AP1 was unaffected by injected fore potential Pitx2 targets.
The Cyclin D1 promoter was reported to be regulatedPitx2 (Figure 4D), indicating that this pathway is stimu-
lated in a Pitx2-independent fashion. Using specific anti- by constitutively active -catenin in human colon cancer
cells based on TCF/LEF binding elements (Shtutman etphospho ERK antibodies, we confirmed that normal acti-
vation of the signaling pathway through ERK phosphory- al., 1999, Tetsu and McCormick, 1999). The Cyclin D2
promoter does not contain recognized TCF/LEF sites,lation was maintained in cells injected with Pitx2
(Figure 4E), suggesting the possibility that Pitx2 might raising the possibility that its induction is dependent on
other classes of transcription factors, such as Pitx2.exert effects on specific transcriptional targets, while
not affecting the initial transduction of proliferative Consistent with this possibility the addition of lithium,
even in the absence of serum, caused some increasesignals.
Highly expressed DNA binding transcription factors can in Pitx2 levels in T3-1 or C2Cl2 cells (not shown) (Figure
5A). Cyclin D2 transcripts were rapidly (30–60 min) andexert transcriptional effects by transrepression; therefore,
Wnt/Pitx2 Pathway in Cell-Specific Proliferation
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Figure 4. Pitx2 Modulates Cell Growth in Mu-
rine C2C12 Myoblasts
(A) Pitx2 and Pax3 coexpression in migratory
precursor myoblasts assessed by immuno-
fluorescence.
(B) Pitx2 expression in C2C12 cells assessed
by immunofluorescence (upper), and West-
ern blot (lower) showing a decrease in Pitx2
levels after differentiation. GM, growth me-
dium; DM, differentiation medium.
(C) Single cell nuclear microinjection ofPitx2
in C2C12 cells caused a 75%–85% decrease
on serum-stimulated BrdU incorporation.
(D) Response to stimulation by AP1 elements.
Microinjections of Pitx2 IgG in C2C12 cells
failed to alter TPA (106 M)-dependent induc-
tion of an AP1-dependent reporter. Results
are in 	 SEM with 300 cells microinjected
in each condition; similar results were ob-
served in two additional experiments.
(E) Staining of C2C12 cells with  phospho
ERK1-specific IgG signaling revealed identi-
cal nuclear localization of phospho ERK1 in
injected (arrows) or noninjected (asterisk)
cells in response to serum. Upper images
show the injected cells stained by rhodamine;
the DAB staining quenches the nuclear fluo-
rescence (upper right image).
(F) Role of DNA binding and N-terminal do-
mains in Pitx2-dependent proliferation
events. The ability of purified, bacterially ex-
pressed GST fusion proteins containing
Pitx2 holoprotein (GST/Pitx2), N terminally
deleted Pitx2a (GST/Pitx2N), C terminally
deleted Pitx2a (GST/Pitx2C), or Pitx2a HDmut
harboring a 3 aa mutation in a 3 helix of the
homeodomain (R45A, V47A, N51A), eliminat-
ing specific DNA binding, were evaluated for
ability to rescue Pitx2 IgG-inhibited BrdU
incorporation. Injection of GST Pitx2a N or
GST Pitx2 HD, GST Pitx2a, and GST Pitx2 C
were also evaluated in the absence of Pitx2.
(G) Photomicrographs of representative
fields of the experiment presented in (F),
showing injected cells (fluorescein), and nu-
clear staining with BrdU IgG (rhodamine).
(H) Proliferation of Rat1 cells was unaltered
by Pitx2 expression. Rat1 cells, which do not
contain detectable Pitx1 or Pitx2 transcripts
or protein, fail to exhibit any growth stimula-
tion on nuclear microinjection of GST/Pitx2,
nor any inhibition of BrdU incorporation with
Pitx2 IgG.
(I) Effects of Pitx2 IgG are maintained until
late G1. C2C12 cells were subjected to nu-
clear microinjection with either preimmune or Pitx2 IgG at indicated times after initial serum stimulation, with BrdU incorporation assessed
after 14 hr. Pitx2 inhibited BrdU incorporation until 8–9 hr after serum addition.
robustly induced upon lithium and serum treatment of ment with LiCl (Figure 5A, and data not shown), consis-
tent with the -catenin-dependent induction of Pitx2either C2C12 cells (Figure 5A), or T3-1 (not shown), with
either treatment alone being insufficient for effective and dismissal of HDAC1. However, simultaneous activa-
tion of both the Wnt/-catenin and growth factor-depen-activation (not shown). Using ChIP analysis in either cell
type, we noted very little, if any, Pitx2 present on the dent pathways, showed a marked increase in histone
H3/H4 acetylation and recruitment of Pol II (Figure 5A).Cyclin D2 promoter in cells maintained in the absence
of lithium or serum, addition of serum alone caused Thus, the Wnt/-catenin and growth factor-dependent
pathways functioned combinatorially in the activationsome appearance of Pitx2 on the Cyclin D2 promoter,
and a marked Pitx2 recruitment occurred rapidly in re- of the Cyclin D2 promoter. Virtually identical ChIP data
was observed in both C2C12 and T3-1 cell lines.sponse to lithium. Consistent with binding of Pitx2 in
the presence of serum HDAC1 were detected, but HDAC Expression of a reporter under control of the Cyclin
D2 promoter was specifically blocked in a single cell2,3,4,5, or 6 were not. HDAC1 was dismissed on treat-
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D2 promoter (Figure 5C). Similarly, there was no effect
of expressing Pitx2 N terminus (data not shown). Nuclear
microinjection of Cyclin D2 and Cyclin D1 IgG signifi-
cantly inhibited serum-dependent BrdU incorporation in
C2C12 cells, consistent with their roles in G1 progres-
sion (Figure 5D).
Actions of -Catenin in Pitx2 Derepression
The rapid induction of the Cyclin D2 gene raises the
question of what additional machinery is required for
Pitx2-dependent activation. Homeodomain activators
can serve as repressors, dependent upon promoter con-
text and culture conditions, based on interactions with
specific corepressor complexes (Pinsonneault et al.,
1997; Xu et al., 1998; Asahara et al., 1999; Scully et al.,
2000). Consistent with these observations, Pitx2 or a
Gal4/Pitx2 fusion protein exhibited repressor activity on
target genes in Rat1 cells (Figure 5E and data not
shown), even though Pitx2 clearly serves as an activator
of growth regulatory genes, as shown here, and on other
promoters (Amendt et al., 1998, Bach et al. 1997). Treat-
ment with lithium chloride, microinjection of constitutive
-catenin, HDAC1 IgG, or the addition of serum all acted
to reverse this repressive function.
Immunoprecipitation from cells transfected with a
Pitx2 expression vector revealed the ability of Pitx2 to
robustly interact with -catenin and with HDAC1, even
at endogenous levels of Pitx2 and -catenin (Figure 5F),
analogous to interactions between TCF/LEF1 and
-catenin. Because -catenin has been reported to in-
teract with HDAC1 (Billin et al., 2000), we evaluated the
potential effects of -catenin on the enzymatic activity
of HDAC complexes by coimmunoprecipitation assay,
finding that HDAC1 activity was inhibited 4–5-fold by
-catenin, while the activities of HDAC2, HDAC3,Figure 5. Pitx2 Regulates Specific G1 Growth-Control Genes
HDAC4, and HDAC5 were not affected (data not shown).(A) Induction of Cyclin D2 by 30–60 min lithium and serum treatment.
ChIP assay was performed using specific Pitx2,LEF1, -catenin,
acetylated histone H3/H4, or Pol II IgGs. Sequential Recruitment of Required
(B) Role of Pitx2 in Cyclin D2 expression. C2C12 cells (shown), Pitx2 Coactivators
or T3-1 cells (not shown) were subjected to single cell nuclear We next wished to define the coactivator machinerymicroinjection with Pitx2 IgG and a construct encoding a LacZ
required for Pitx2-dependent activation of these growthreporter under the control of the Cyclin D2 promoter.
control genes (Hermanson et al., 2002). Both Pitx2 and(C) No difference was recorded in Cyclin D2 expression by Pitx2
IgG in Rat-1 cells, in which Pitx2 is not expressed. -catenin were highly recruited to the Cyclin D2 pro-
(D) Microinjection of Pitx2, Cyclin D1, or Cyclin D2 IgG inhibits moter at 30 min and remained bound at all time points
BrdU incorporation in C2C12 cells. evaluated (Figure 6A). We examined the potential re-
(E) Pitx2 can function as a -catenin-regulated repressor, Gal4/Pitx2
cruitment of specific components of several well-char-caused repression of UAS/tk reporter in Rat1 cells, using the single
acterized coactivator complexes, at various times aftercell nuclear microinjection assay. Addition of lithium chloride, serum,
lithium and serum stimulation. Based on our previousexpression of constitutively active -catenin (-cateninc), or H-
DAC1 reproducibly overcame the repression of UAS/tk reporter by observation (Bach et al., 1997) that Pitx2 was capable
Gal4/Pitx2. of interactions with NLI/Ldb/CLIM coactivators, initially
(F) Pitx2 interacts with HDAC1 based on coimmunoprecipitation identified by interactions with LIM homeodomain factors
from cell extracts prepared from 293T cells transfected with HA-
(Agulnick et al., 1996; Bach et al., 1997; Jurata et al.,Pitx2 and Flag-HDAC1 expression plasmids. Pitx2 interacts with
1998; Jurata and Gill, 1997), we evaluated their potential-catenin in cell extracts prepared either from 293T cells transfected
recruitment on the Cyclin D2 promoter. NLI/Ldb/CLIMwith HA-Pitx2 and -catenin expression plasmids, or by coimmuno-
precipitation from untransfected, lithium-treated T3-1 cells (shown) was recruited by 30 min, in lithium/serum-treated cells,
or C2C12 cells (not shown). at much decreased levels at 60–90 min, and again ro-
bustly at 120 min (Figure 6A). CBP/p300 were clearly
recorded at 30 min but declined markedly by 60 min
and subsequently were undetectable (Figure 6A).nuclear microinjection assay in C2C12 cells by Pitx2
IgG, further supporting the direct requirement for Pitx2 Based on the continued acetylation of histone H3 and
H4 after CBP/p300 was dismissed (Figure 6A), we exam-in Cyclin D2 gene activation in these cell types (Figure
5B). In contrast, in Rat 1 cells, which do not express ined the potential recruitment of the MYST family mem-
bers of histone acetyltransferases. As shown in FigurePitx2, Pitx2 had no effect on expression of the Cyclin
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Figure 6. Recruitment of Coactivators to the Cyclin D2 Promoter
(A) Recruitment of coactivators on Cyclin D2 promoter in C2C12 cells, after stimulation with lithium and serum revealing that specific coactivators
were recruited in a temporally specific fashion. Examples of controls are shown on the right.
(B) Pitx2 interacts with Tip 60, CBP/300, and CLIM in coimmunoprecipitation assay from C2C12 cells both in transfected cells (Flag) and at
endogenous levels in T3-1 cells.
(C) The role of coactivators on activation of the Cyclin D2 promoter. C2C12 cells were microinjected with specific antibodies against Pitx2,
CLIM, Tip60, CBP/p300, PBP, and a construct in which the Cyclin D2 promoter drives a LacZ reporter.
(D) Failure of these same antibodies to alter expression of tk/LacZ reporter with single cell nuclear microinjection in C2C12 cells.
(E) Ability of dominant-negative forms of Pitx2 (Pitx2 N terminus), NCI/Ldb/CLIM (CLIM C terminus), or Tip 60 HATmut expressed as CMV
transcription units, to inhibit Cyclin D2.
(F) Ability of Pitx2 to recruit specific coactivator complexes, comparing a minimal promoter (p36 LacZ) transcription unit and the same
transcription unit containing a 3 
 Pitx2 response element.
6A, Tip60 recruitment was not evident at 30 min but was each protein (Figure 6B), as well as interactions between
Pitx2 and NLI/Ldb/CLIM and CBP (Figure 6B). Theserecruited to the Cyclin D2 promoter at 60 min in response
to addition of lithium and serum and TRRAP was also data are consistent with Pitx2-dependent recruitment
of distinct coactivator complexes. As reflected by thedetected in a similar temporal pattern, consistent with
recruitment of a TRRAP/Tip60 complex. Tip60 is present presence of PBP/TRAP 220/DRIP 205, the TRAP/DRIP/
ARC complex (reviewed in Hampsey and Reinberg,in many complexes, including the DNA repair complex
(Ikura et al., 2000), which does not effectively produce 1999), also appeared to be recruited by 60 min, dis-
missed at 90 min, and again robustly present at 120 minhistone H3 acetylation complexes. The absence of
TAP54 and BAF53 suggests that the recruited Tip60 (Figure 6A).
To evaluate the potential roles of each of the seriallycomplex is distinct from the repair complex (Figure 6A
and data not shown). The recruited TRRAP/Tip60 com- recruited complexes in activation of the Cyclin D2 pro-
moter, single cell nuclear microinjection assays wereplex is dismissed by 120 min. In addition to the ability
of Pitx2 to interact with -catenin (Figure 5F), immuno- performed in C2C12 cells (Figure 6C). Intriguingly, spe-
cific blocking of antibodies against CBP/p300, Tip60,precipitation experiments in C2C12 cells revealed a spe-
cific Tip60/Pitx2 interaction at endogenous levels of NLI/Ldb/CLIM, and TRAP/DRIP/ARC entirely inhibited
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Cyclin D2 promoter activity, as did anti--catenin IgG example because its deletion causes a failure of cell
type-specific proliferation at specific stages of develop-(Figure 6C). Therefore, the temporally specific recruit-
ment of specific coactivator complexes to the Cyclin D2 ment, defining a Wnt-dependent pathway regulating
proliferative events in cardiac outflow tract, pituitary,promoter upon binding of Pitx2, appears to be required
for activation of the Cyclin D2 gene. As a further control, muscle, and other tissues. This role of Pitx2 may extend
to several other tissues, including colon and tooth bud.we show that injection of IgGs did not affect other tran-
scription units (e.g., tk or CMV promoters), confirming Our data are consistent with the postulate that the Wnt/
-catenin → Pitx2pathway regulates cardiac outflowpromoter specificity (Figure 6D and data not shown).
To utilize an independent method to assess the func- tract development, in addition to its pivotal role in brain
and craniofacial development (Brault et al., 2001, McMa-tional roles of these cofactors, we expressed dominant-
negative forms of these factors. The N terminus of Pitx2 hon et al., 1992, Megason and McMahon, 2002). We have
demonstrated that Wnt signaling, in acting upstream ofis required for its actions in proliferation (Figure 4F) and
can itself serve as a dominant-negative for proliferation Pitx2, directly induces Pitx2 gene expression, based on
the recruitment of LEF1 to evolutionary-conserved sitesin C2C12 cells (Figure 4F). We also observed that Gal4
DBD/Pitx2a N terminus fusion protein inhibited actions in the Pitx2 gene 5-regulatory regions, with a regulated
exchange of HDAC1 for -catenin occurring on theseof Pitx2 holoprotein in transient cotransfection assays
(data not shown), and we therefore used this protein as Pitx2 sites. Pitx2 is expressed in the cardiac neural crest
as these cells migrate from the dorsal neural tubea dominant-negative, showing that Gal4/Pitx2aN selec-
tively blocked Cyclin D2 activation in C2C12 cells through the fourth and sixth branchial arches, and Pitx2-
expressing cells exhibit defective proliferation in both(Figure 6E). In contrast, Gal4/Pitx2a C had no effect
(Figure 6E). Further, the C-terminal activation domain of Wnt-1 Cre/-cateninflox and Pitx2/ mice. This leads to
a marked diminution of cells arriving in the outflow tractCLIM/Ldb/NLI, fused to Gal4 DBD, which inhibits ac-
tions of the holoprotein, also blocked Cyclin D2 activa- and consequent lack of septation of the great arteries.
Thus, we have documented a genetic and biochemicaltion (Figure 6E). To further test that the antibody block
was specific and did not merely reflect removal of com- linkage between Pitx2, as a critical target of the Wnt
pathway with respect to cardiac outflow tract and pitu-plexes, we performed a rescue experiment with CBP. In
the presence of CBP, expression of wild-type CBP fully itary proliferation.
Because multiple components of the Wnt/Dvl/-cate-rescued Cyclin D2 expression, while expression of CBP
harboring point mutations that abolished HAT function nin → Pitx2 pathway are dosage sensitive for these
events, these findings suggest a common etiology for(CBPHATmut) (Korzus et al., 1998) did not (Figure 6E).
Because ChIP assay cannot determine whether co- the highly prevalent multigenic cardiac outflow tract ab-
normalities that occur in the human population (Chien,factors are recruited by a specific DNA binding tran-
scription factor, we wished to confirm that the factors 2000; Srivastava and Olson, 2000). The events in cardiac
outflow tract development appear to be similar to thoseshown to be bound to the Cyclin D2 promoter in ChIP
assays and to interact with Pitx2 by coimmunoprecipita- in pituitary and muscle, where biochemical analyses and
primary cell cultures reveal that the Wnt → -catenintion could be directly recruited by Pitx2 and required
for its activation and function by an independent assay. pathway directly induces Pitx2 gene expression, based
on the recruitment of LEF1 sites in the Pitx2 gene 5-We therefore used ChIP analysis in C2C12 cells to evalu-
ate the recruitment of these factors to a minimal pro- regulatory regions (Figure 7).
The genetic linkage between the Wnt/Dvl2 pathwaymoter containing a 3 
 Pitx2 response element (Figure
6F). We found that, dependent upon the Pitx2 DNA bind- and Pitx2 in cardiac outflow tract proliferation is consis-
tent with previous data (Thomas et al., 1991; Treier eting sites, Pitx2 was recruited along with Tip60, NLI/Ldb/
CLIM, CBP/p300, PBP, and -catenin, supporting the al., 1998, Serbedzija et al., 1996) that established in vivo
proliferative roles for Wnt factors in pituitary organ de-model that these cofactors can, indeed, be directly re-
cruited to the Cyclin D2 promoter by Pitx2, although velopment. Our data suggest that in pituitary, muscle,
and cardiac neural crest cells, the Wnt pathway servesother DNA binding factors are likely to participate in this
recruitment. Single cell nuclear microinjection of each as a major signaling mechanism regulating Pitx2 gene
expression.cofactor-specific antibody, or expression of dominant-
negative forms of these cofactors on the Pitx2 response
element-dependent promoter, revealed that the factors A Wnt/Dvl/-Catenin → Pitx2 Pathway Regulates
required for activation of the Cyclin D2 promoter were Cell Type-Specific Proliferation
also required for activation of the Pitx2 site-dependent Activation of the Wnt pathway results in rapid recruit-
promoter (Figure 6G). ment of the Pitx2 gene and binding of Pitx2 to promoters
of specific growth control genes. This linkage between
the Wnt pathway and Pitx2 gene expression providesDiscussion
an insight into the molecular mechanisms of cell type-
specific proliferation, based on the required actions ofThe Wnt/Dvl/-Catenin → Pitx2 Pathway
in Cardiac Outflow Tract Development Pitx2 to activate specific, critical growth-control gene
targets acting in G1. Based on in vivo studies, as wellIn this manuscript, we have demonstrated that pathway-
specific induction of a tissue-restricted transcription as the actions in pituitary and muscle cell models, Pitx2
is required for normal proliferation when expressed infactor can provide a critical requirement for proliferation
in specific cell types, providing a cell-specific code for heterologous cells; Pitx2 can actually inhibit proliferation
(Wei and Adelstein, 2002). We speculate that this mayregulating growth. The Pitx2 gene provides a striking
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Figure 7. Model of a Wnt/Dvl/-Catenin → Pitx2 Pathway Regulating Cell Proliferation
Pitx2 serves as a direct LEF-1 dependent target of a Wnt/Dvl/-catenin pathway, and binds to the Cyclin D2 promoter, as well as growth-
promoting genes. With growth factor stimulation, Pitx2 serially recruits a series of coactivator complexes indicated in the schematic diagram
that includes NLI/Ldb/CLIM and Tip60/TRRAP factors, all of which have proved to be required for stimulation of these promoters. An additional
level of regulation appears to be provided by -catenin interactions with Pitx2 (illustrated on the Cyclin D2 promoter), causing dissociation
of HDAC1, serving as a derepression strategy.
occur by squelching coregulatory factors required by Pitx2 are likely to also mediate cofactor complex recruit-
ment to the Cyclin D2 promoter.DNA binding transcription factors that exert analogous
functions to Pitx2. To subserve its proliferative effects, The role of Tip60 is consistent with the actions of
Esa1P, a Tip60 homolog in yeast, that acetylates histonePitx2 must bind to its cognate DNA sites and requires
an N-terminal activation domain, but not the C terminus, H4 and is required for normal cell cycle (Howe et al.,
2001). The HAT functions of both CBP/p300 and Tip 60which is consistent with a previous report of inhibitory
effects of the Pitx2 C terminus (Amendt et al., 1998). appear to be required for Cyclin D2 activation, whereas
the serial recruitment of distinct acetyltransferases mayTogether, our data suggests that three independent
events underlie Pitx2-dependent activation of cell type- be required for acetylation of specific histone residues,
as well as to modify non-histone transcriptional compo-specific proliferation: Wnt-dependent activation of
Pitx2; Wnt and growth factor-dependent relief of Pitx2 nents.
These data point to an intriguing cell-specific modelrepression function; and serial recruitment of a series
of specific coactivator complexes that act in a promoter- for coordinated regulation of specific growth control
genes, with E2F-independent regulation of Cyclin D2specific manner, analogous to effects of -catenin on
LEF1 (Billin et al., 2000). occurring in response to signal pathways that induce
or control cell-specific factors. In turn, activation ofWhile it is possible that Pitx2 may influence the cell
cycle at more than one stage, we have shown that Pitx2 Cyclin D2, as well as Cyclin D1, is required for inactiva-
tion of Rb-related pocket proteins that inhibit transcrip-exerts key actions in early to mid G1 and stimulates
expression of specific growth control genes exemplified tion on a series of growth control genes. Induction of
Cyclin D2 in cell types not expressing Pitx2 has beenby Cyclin D2. The Cyclin D2 promoter intriguingly has
not been found to harbor functional E2F sites (Ren et recently reported to be sensitive to c-Myc, which inter-
acts with a TRRAP complex (Ikura et al., 2000; Bouchardal., 2002). Pitx2 thus provides a direct nuclear target for
interactions between the Wnt and growth factor path- et al., 2001).
ways in mediating cell type-specific regulation of growth
control gene expression. Implications for Regulation of Proliferation
by Cell-Type Specific FactorsIn a fashion reminiscent of the regulation of the HO
locus in yeast (Cosma et al., 1999), there is a sequential While the findings presented in the manuscript provide
a molecular explanation for the synergistic actions ofrecruitment of specific, required coactivator complexes
that include the CBP/p300 complex, the NLI/Ldb/CLIM the Wnt pathway and growth factors in stimulating prolif-
eration in Pitx2-expressing cells, they also raise thecoactivators of LIM homeodomain factors, and the
TRAP/DRIP/ARC complexes. We suggest that there is question of whether factors analogous to Pitx2 function
in other cell types. We suggest that in cell types thata requirement for the actions of initially recruited com-
plexes in the subsequent recruitment or actions of later do not express Pitx2, other factors, including other ho-
meodomain proteins, substitute for the actions of Pitx2components, in light of the roles of the serially recruited
complexes in HO gene regulation during cell cycle in activation of specific growth-regulating genes, serv-
ing as distinct competence factors, perhaps requiring,(Cosma et al., 1999). DNA binding factors other than
Cell
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